50453891 4
`
`09/08/201 7
`
`PATENT ASSIGNMENT COVER SHEET
`
`Electronic Version v1.1
`Stylesheet Version v1.2
`
`EPAS ID: PAT4585621
`
`
`SUBMISSION TYPE:
`NEW ASSIGNMENT
`
`NATURE OF CONVEYANCE:
`ASSIGNMENT
`
`CONVEYING PARTY DATA
`
`Execution Date
`
`ALLERGAN, INC.
`
`RECEIVING PARTY DATA
`
`09/08/2017
`
`SAINT REGIS MOHAWK TRIBE
`Name:
`
`Street Address:
`412 STATE ROUTE 37
`
`City:
`AKWESASNE
`
`
`
`
`
`
`State/Country:
`Postal Code:
`
`NEW YORK
`13655
`
`PROPERTY NUMBERS Total: 6
`
`Property Type
`8629111
`Patent Number:
`
`Patent Number:
`8633162
`
`Patent Number:
`8642556
`
`Patent Number:
`8648048
`Patent Number:
`8685930
`
`Patent Number:
`
`9248191
`
`CORRESPONDENCE DATA
`
`(714)246—4249
`Fax Number:
`Correspondence will be sent to the e-mail address first; if that is unsuccessful, it will be sent
`using a fax number, if provided; if that is unsuccessful, it will be sent Via US Mail.
`Phone:
`714—246—4500
`
`Email:
`Correspondent Name:
`Address Line 1:
`Address Line 4:
`
`patents_ip@allergan.com
`ALLERGAN. INC.
`2525 DUPONT DRIVE, T2—7H
`IRVINE, CALIFORNIA 92612—1599
`
`
`ATTORNEY DOCKET NUMBER:
`17618
`
`LAURA L. WINE
`NAME OF SUBMITTER:
`
`SIGNATURE:
`/Laura L. Wine/
`
`DATE SIGNED:
`
`09/08/2017
`
`Total Attachments: 6
`
`504538914
`
`PATENT
`REEL: 043532 FRAME: 0422
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`source=Short form-Patent Assignment - Signed#page1.tit
`source=Short form-Patent Assignment - Signed#page2.tif
`source=Short form—Patent Assignment — Signed#page3.tif
`source=Short form—Patent Assignment — Signed#page4.tit
`source=Short form—Patent Assignment — Signed#page5.tif
`
`source=Short form—Patent Assignment — Signed#page6tif
`
`PATENT
`REEL: 043532 FRAME: 0423
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`{EYIL’CEI‘‘I'i’UA? ¥"ER5‘IGN
`
`8'30}??? FURM PATENT ASSEGE‘E‘MENT
`
`This Fatwa Maignmem (ibis “Assignmem‘? £3 matte 33 (3f Segtembea‘ 8y 283?
`{$31033 (12to the "Effascfivg 333%”), by md fieiwem Mifiagm“, $3322.? a Deiawasm wrmmtixm
`{“Asfigmrm and Sam: Kggis Mfii’m‘wk Taber. a fedwaiiy‘mwgmxed mvsmign Naive»
`magmas: "friha {“Assigme“).
`
`W’Hfiififis‘xfi Asesignm GWfiS the pmenés and paw: aggziicatiens Set! forth in
`Afiachamn‘i A ($138 Wilma???
`
`WHIiREAS, Amiga}: {imimg {a asségn, Mrmfisr, came}? mini dalii-‘ar £0
`Amiga-g and Assigmee wifims to asqufim {mm Assigmn $15 erf ifs rigbi aim and imtemsi in, me
`and under $216 Pazams; mm
`
`WHEREAS? pmuam my and won the 2mm, aifls’gfifims and canfiitissns 0&2. aim
`Fatem ésségxmmt Agmsmmm mm $3 9f Sagatamba: 3, 2617 mm “bong 33mm Agreamwt“),
`1}}! mm 156an Axsignox' and Assignem wgigmw dissirw ts) cmfirm and perihai 111$ maigumemt,
`tmnafm; canvaymw and aiafivm m magmas: at“ aii 0?“ m fighi; tizia and imam-gt in, to and
`maxim the: Paints anal in; w and mfifir the: inwmiqms ragregezfisé Wacky, and Asgignw is
`{istsirous sf aflnfimifig gm yerfmting ma same,
`
`MSW, Ti-iERi-EFOEE, f0: geod imai vaiuahia camidami‘ian, ma s‘maigt and
`sufi'iciwuy of wfiich 21m Mushy acksmwlwgcsi, {Em minim 118mm,
`iaztmxdizzg is: bx: Eagafiy
`Maxim 'immhy agave $13 faxiis'sws:
`
`E. Axasggmmm As 9f me Eifactim flats, Assign): hereby mnwys, {musfk‘m assigns
`anti delivgrs tfi Asasignee, 3222i Assigns: hereby gazaptts the $031 Aissigmr,
`9111 of
`Assignmk fights tifie and ixfimwz im in 9.316 umier 31w Patients, {ogetiiasr with any
`reissuss, reaxammrmu, éivisiem§ matimsmimzs, mutinufitis‘am‘mwpmg extemzimrs, and
`mnfiwals 91" am}; Amigzged Pfitams aimazi}! gmmexi m3 Wifiiafiiu may 2323: gfii‘ifitfiid fixarcen
`Tim mfiigfimfin: acmtamgxiaifié keratin ifi mam? m be 3m aiamim'e amignmem mg? m: £13;
`way cf smurity
`
`Ens:
`
`tM
`
`§;L(§3§§;§g§§§§gg§§. As may be mammary, Assigmr 531331 execute! aa‘mmviadgg and
`éaliver such Omar iastmmemg, dficnmem‘g amt $§I§€mems wd shak? do such miter
`{Mags as may he mazsmmbiy smmzsary, Elffigfifir or esdvisai‘sfie is: came out its csfiiigmioas
`amiar {his Agraemem' mid $3 may tie reasmzabiy mmgwy, 5:503:33}? er advisable: as mere
`mmfiawiy caffactuaize, sonaumgmm. WGOR‘L perfhxsi ear amzfirm 9132:: h‘ammations
`mni‘smfiamé hamby.
`
`Eggmmzzttimg. The Assigm hersi: ' authmizes the {Dimmer cf Pamms amfi Traésmarks
`in :12: United States F3233): and Trademark Gffice ta) remix! Aszsigsme as the 33$ng
`and mama: of 3:123 Assigned Fatwa»: Md :0 éeliver to Aa‘xsignee}, and {as Assignee‘s
`atwmfiya‘ agentx, Ssmzeswm 92' awigm, $11 fiffiifiiiii daxmmeaxm aw mummmicafims as
`may 3w warmmzxi by wig; :fisgigtimrsm, iamiudiag but amt Simitm‘i w igwmg (my and all
`Lmew Patierma :3? mg :3sz $3333 0:3 im'emims «flamed in the Pawns
`
`
`’a:;gsfig§§ggg§§j§gg§gmgmnj§i. Awignez: 2‘6§$‘63831i$ {hat fit mm m): mad wfli
`4. N0 0:333
`mt waive its sm'emign immmity or {ha savemgn immunity sf any campany,
`(enigmmimm emeaprisg, auihfimy, éivisiem. subiivésism Emma}; or (film: agency:
`
`imsarmzzmimlity m“ aims” gowmmwt wmmnexat 0f éfisigme {gawk (sf the ibregoimg
`
`
`
`
`E
`
`3'?
`“x,
`
`53% $1?“
`REEE. 0%3532
`
`fig
`o T
`R ‘ME: 0424
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`mciudisg Asségms, a ‘Tribai flirty“; hr: each case, in misfit-3n in any Ema: pangs
`mviaw m any 0mm" pmaeedmg is: the United States Patem & ‘E'mdemark (fifties Gr any
`agiminigémiéve pmcmfing that may be flied far 3%»: paupusg gi’ imgiidaamg m- reném'izxg
`anazzfamwtale any :kggigmd f’aiwafis, For puspmfis {If {big Aasignmemt Agmememt. aw
`pmvisism {sf this Awigflmefli ngj‘fifimfiffli shzmki 3m imamra‘smd tr: mmfimw a: waivm‘ 53f
`Amigms’g at any mm!” mm: §}&x‘iy‘a gowns-ig1: immumly as m arty mm mamas wvisw
`a: sémiiar mmedmga
`
`5’3.
`
`
`mprefimmtémgs, wan‘mfiiesy wwamfisg ehiigaiinms and mixer {ems :zonmineii in {31%
`Lang Pom: Agzwmam m2! fiat 313 Snmmémi harem; ME 3w; mam in 23:31 farce
`and effect :9 the 231% amen: grgwigiad {harem Te aha: amen: am:- my pmviaim at“ this
`Assignmmz iv; imamiem’m at mmflmm with the E3233 Farm Agrmmem, #22:: gzmvisiem
`Qffihe L053 Farm Agreamemt shaéi central. Tm parties may awaits thiia Aggigfimmt
`in maltéple counmapms, my me of which amé no: warms; the sigmmm 3f more than
`me: gafiy, Rm: 3%} swab counterparts mien togsszimr shafl cmstimts me and me same:
`izmmmcm‘ Any caiiunterpam :my be: execumd by {msmiia a: PBS}? signature and such
`§a¢§im§i¢x {3: FM“ sigmiismfi $13,321 E36 fiamneé am nfigiml. The {arms anti mmfiitims a?
`£3113 Aasi gmyem 5512225 be $231116!ng mm} the pmirzs Emma ms: Kiwi: mapmfiw suamsscm
`and asazégm, This Assignmen: man be gemmcé by and cmmmmfi in aacomfiamcc with
`the iawa of the Sate {)5 NEW E’m‘k, Milieu? giviag 81’me :0 {he paisscigies of sorzfl’mis
`cf haw :hmgof,
`
`{Signm‘zmm .eiypmr 9;: His fififmving Pngs'}
`
`b};
`
`M
`5} § “
`
`
`
`REEL$M353
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`EN Wi’iTNESS 'I’MREQF, ASSigmr anti Afisignei: have: uaufigd their mspmtive éufiy
`wflmfizcd (si‘fiwm to enema ifiis Asfiigmnem as 35:11:: Effective Date.
`
`Saint Regis Mchawk Tribe
`
`Alfiergang 11:62.,
`
`figsifigm
`
`
`
`Name: A; Mama: 1}? 38312:;
`
`”rifle:
`
`Naéae: Sawfly ka
`
`Tiiie: Tribal Chief
`
`. s ,.
`“d
`5533 fififigfiwfiw..........
`Name: Michaei (Emma:
`
`Tifie: Tfibai Chief
`
`.fi‘igmmm Fizgg w 3331:)” Fwy}: Pawn: ahxz‘gmmmi .efgresm‘erz; .
`x?
`
`*
`P TE
`REEE$G43§32 F%ME: 0426
`
`{A
`
`~
`
`
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`fixfiaciggmm A T322: Faggagg
`
`
`
`
`
`
`....E.§,:§;§i§§im WEE”"3157E??.
`
`.31.“?AK?”
`
`j?
`_
`I
`., W‘
`’?
`
`EE;3«E:E,5:EEE.
`'
`«EEEEEE
`UNEMEEEQ
`EEAug“m3
`8,648,043
`“meEEEEE E
`EEEEEE EESS
`UinAgEE'QE‘EME
`EEEEEEE325;
`
`
`
`
`
`
`
`
`
`
`
`Abe'méoned
`., Abandmed
`
`_
`
`Fading
`Abammd
`
`Z‘filanfiélé
`:s/EEEEE59
`.. EEEEEEEEEEEEW"ESWQTEGE‘JW
`EEEE§2735E
`
`E
`
`'
`
`EEEEW 335 Efir‘fififlaémnm
`
`”Abanfimcfi
`g5 ‘
`iii’%9$,5§5
`i
`“fix“...u...
`“‘E-u-«Aiukwa
`“.4w:“%.______._...__.
`:
`méxEEEEEEEiEEEEEEEi
`"EHE31306?)
`E E1.3$34361"
`. MW : W
`
`
`
`E
`
`EE'4?9.4§1
`EEEEEE ESE?
`E£/§3?M$
`‘
`
`.
`‘
`
`AEEEEEEEEEEE
`EEEEEE46E
`
`Abamsw EA
`
`Abmdmui
`
`mmm M
`
`9,§Q§,5’?<$
`
`WEEEE LEEE"
`
`Aflzzcémem‘fi 1‘2: 3?ng Form Paiem aissignmmi égwemmf'
`5;ng1)st
`
`EEK?“
`
`RE
`
`2;“
`EPA 5m
`
`0435 2 FRAME: 0427
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`
`
`
`
`§§SREALNG, E FILWGEEAE‘E NE
`
`E
`
`
`85'75 .108
`8$36)?31}
`”E
`_"
`‘
`14.13771:15???
`@5635M8
`
`(imam ,
`
`
`
`m‘mflL‘W‘*.W“.
`M41113:8
`;
`ahaxsfiam‘l
`swigugam 1
`{Emma
`2~Aug¢813
`WWW
`
`A iimaefis
`E~Mw20£fi
`
`
`
`
`
`‘
`
`.
`21308
`........w+mm
`({fit-«2'31'7
`«—-~E
`
`Akandmad
`
`E’méing
`Lawmi mei§§unfi§
`Lapmé E‘mvisimmi
`
`Abanfianm
`
`Rpm} Ekz‘vmmml
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`
`WW 2 ‘www--------------w
`memwm “m“
`fxmmNfl. E Efisug BAN E Samufin Lhasa 95313 g
`STATBSHFOMM‘MM E
`
`
`~
`E
`v
`5121 74,324 i E—May»300§
`a..apsazd vaisimaim
`US
`M
`
`
`
`
`2 EMA}3929 E
`Mpg-ad Pmma(mat-W
`"
`-
`=
`=
`
`
`
`
`:
`US
`a
`'
`~»
`Hi 1 15,?64
`1 MM»?3} E
`Abanéflmfi
`
`‘MWEWAAHAWEW...
`:
`«
`*
`24524$55
`a
`2’?Qcfl-2&14
`Fmfimgwm_.
`
`
`
`‘
`‘
`ié~Ang—3fi§3
`Ahawaned
`§6~Ap§m20§ 1-?
`Abandaned
`
`Panding
`
`
`
`Abwdsmé
`Ahfimfiemé
`
`15Ayrvl‘fié
`
`
`
`mefiééés " 3
`225chnm
`
`
`Fenggng
`
`“A
`
`
`
`AI!geclztziem «=3 m 3:5:er Poms;; (25$)?! xixxignmm: xigresmgnt
`
`RECORDED: 09/08/2017
`
`“£248
`
`§PA g: 2-
`REEL: 0435
`FRAME: 0429
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01131
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`